Complete Symptom Resolution with Empirical Antimicrobial Treatment Despite Negative SIBO and Stool Testing in Functional Bacterial Overgrowth

A young adult male presented with a two-year history of progressive gastrointestinal dysfunction that began during his transition to college. His clinical picture was characterized by severe immediate postprandial bloating, chronic diarrhea, and frequent vomiting episodes occurring both with and without food intake. Beyond his acute gastrointestinal complaints, he carried diagnoses of Hashimoto's thyroiditis (managed on levothyroxine), active psoriasis, and active asthma—suggesting broader systemic immune dysregulation.

The patient's medical history revealed substantial cumulative antibiotic exposure: a month-long hospitalization during adolescence for a ruptured appendix requiring extensive antimicrobial therapy, recurrent strep throat infections treated with multiple antibiotic courses throughout childhood, and notably, amoxicillin prescribed following wisdom tooth extraction that temporally coincided with the onset of his gastrointestinal symptoms^[4][4]. Despite initially attributing symptoms to lactose intolerance, postprandial diarrhea persisted after dairy elimination and a normal stool panel ordered by his primary care physician.

This case presented a diagnostic paradox: compelling clinical features suggestive of functional bacterial overgrowth with heavy antibiotic burden, yet entirely normal objective diagnostic testing. The clinical question centered on whether empirical treatment based on pattern recognition alone could achieve therapeutic success when standard diagnostics failed to provide mechanistic confirmation.

At initial presentation, the patient described escalating symptoms in the weeks preceding consultation. He reported frequent vomiting episodes occurring both with and without food intake, notably without associated nausea. Most striking was the development of severe, immediate postprandial bloating—onset occurring within minutes of eating or drinking—progressing to the point where he described his stomach as "blowing up huge." He also experienced chronic diarrhea, occasional gas, and infrequent heartburn. The patient maintained an otherwise healthy, well-balanced diet and was not overweight; if anything, he was trending slightly underweight.

At the eight-week follow-up, the patient demonstrated significant symptomatic improvement with the strict elimination diet consisting primarily of meat and fruit. Sleep quality and energy levels improved markedly. Vomiting resolved completely. Stool consistency normalized substantially, though not entirely. Even his asthma and psoriasis showed mild improvement. However, severe bloating persisted—described as unremitting and proportionally significant—with sourdough bread identified as a pronounced trigger.

By the twelve-week follow-up, bloating had worsened to severe levels. The patient reported waking each morning already bloated and distended, with urgent need for bowel evacuation upon rising. Symptoms persisted regardless of stress levels or environmental changes; a vacation provided no relief. Both solid and liquid foods triggered bloating. Partial symptomatic relief was achieved through activated charcoal, digestive enzymes, hot showers, and heating pad application. Eating smaller meals slowly with thorough chewing reduced severity but did not eliminate symptoms. The patient expressed significant distress, articulating that the results "made no sense" given symptom severity and that he felt he "could not be normal."

At the twenty-two-week follow-up, approximately ten weeks after empirical protocol initiation, the patient reported complete resolution of all presenting gastrointestinal symptoms. Bloating, vomiting, diarrhea, morning distension, and urgency were all absent. He described the outcome as life-changing and stated unequivocally that his symptoms had completely disappeared.

The diagnostic results created significant clinical dissonance. Both the comprehensive stool panel and the three-gas breath test returned entirely normal, providing no objective evidence of dysbiosis, pathogenic organisms, or small intestinal bacterial overgrowth. The GI Effects panel provides only a luminal colonic snapshot and does not assess the small intestine. The clinical pattern—immediate fermentative bloating within minutes of eating, sourdough reactivity, documented antimicrobial exposure, morning distension on an empty stomach, and historical improvement with charcoal—remained highly suggestive of substrate-driven gas production in the proximal small bowel despite negative testing. This paradox between thoroughly normal diagnostics and compelling clinical presentation formed the basis for empirical treatment.

The clinical presentation suggested gut dysbiosis with possible bacterial overgrowth. The convergence of a heavily antibiotic-laden history, the temporal relationship between amoxicillin use and symptom onset, and the presence of both Hashimoto's thyroiditis and psoriasis pointed toward a systemic immune and inflammatory picture. The patient was transitioned from levothyroxine to a combination thyroid product (NP Thyroid), and digestive enzyme supplementation was initiated. He was prescribed a strict elimination diet consisting primarily of meat and fruit, designed both to identify trigger foods and to reduce luminal antigenic load while awaiting objective diagnostic data. Following the eight-week follow-up showing persistent severe bloating despite dietary improvement, the patient was initiated on a low fermentation diet.

Faced with two entirely normal objective diagnostic tests yet confronted by a clinically compelling presentation, the clinician made the decision to treat empirically based on the constellation of clinical findings rather than await further diagnostic confirmation that might never arrive. The clinical pattern—antibiotic burden, immediate fermentative bloating profile, temporal symptom onset coinciding with amoxicillin use, morning distension on an empty stomach, and historical improvement with charcoal—remained highly suggestive of functional bacterial overgrowth, possibly distal SIBO or a false-negative breath test.

A comprehensive ten-week empirical treatment protocol was implemented. Antimicrobial cycling was chosen over single-agent therapy to broaden coverage and reduce the risk of adaptive resistance. Microcidin and Microcidin AF (VitaAid Professional Therapeutics) were alternated on a weekly basis: Microcidin during weeks 1, 3, and 5, and Microcidin AF during weeks 2, 4, and 6, with titration from 1 capsule once daily to 2 capsules twice daily as tolerated. Motility and symptom support included peppermint oil (Protocol for Life) at 1 capsule once daily with food as needed, and ginger extract (Pure Encapsulations) at 1 capsule twice daily between meals on an empty stomach. Digestive support with Gastro Comfort with Pepsin GI (Now Foods) at 1 capsule twice daily was prescribed for the first eight weeks.

Importantly, microbiome restoration with MegaSpore Biotic was intentionally delayed until week 7, and prebiotic fiber reintroduction with Sunfiber (Tomorrow's Nutrition) was graduated beginning in week 8, escalating from 1/4 scoop to 1/2 scoop to a full scoop over three weeks. This staging was deliberate: supplementing probiotics and fermentable fiber during active antimicrobial therapy risked feeding any residual overgrowth and re-triggering fermentation before the luminal environment was adequately cleared.

At the twenty-two-week follow-up, approximately ten weeks after protocol initiation, the patient reported complete resolution of all presenting gastrointestinal symptoms. Bloating, vomiting, diarrhea, morning distension, and urgency were all absent. He described the outcome as life-changing and stated unequivocally that his symptoms had completely disappeared.

The patient's antimicrobial treatment was associated with complete symptomatic resolution. The MegaSpore Biotic was never initiated per patient preference, though the antimicrobial agents were continued beyond the planned six-week window at the patient's direction. All remaining protocol elements were completed as recommended. The patient achieved complete resolution of a two-year history of progressive, treatment-refractory gastrointestinal dysfunction that had failed to improve with dietary modification alone and had not been explained by standard objective diagnostic testing.

This case illustrates a critical clinical principle: negative diagnostic testing does not exclude functional diagnoses. Despite two thoroughly negative objective tests—a comprehensive stool panel and a three-gas breath test—clinical pattern recognition guided empirical treatment. The patient's antibiotic burden, the specific fermentative bloating profile, the temporal relationship to amoxicillin exposure, the immediate postprandial onset, and the broader context of systemic immune involvement (Hashimoto's thyroiditis, psoriasis, asthma) together formed a compelling clinical narrative. When objective testing failed to provide mechanistic explanation, the clinical pattern itself became the basis for intervention.

The diagnostic limitations encountered in this case are well-documented in the literature. Breath testing for SIBO has recognized limitations including variable sensitivity and specificity, false-negative rates related to sampling location and timing, and inability to detect distal small bowel overgrowth or non-hydrogen/methane-producing bacterial populations. Similarly, comprehensive stool panels assess only the colonic luminal microbiome and provide no information about small intestinal ecology. The convergence of normal testing with compelling clinical features may reflect true functional bacterial overgrowth beyond the detection threshold of current diagnostics, alterations in microbial metabolic activity rather than absolute abundance, or post-infectious visceral hypersensitivity amplifying responses to normal fermentative processes.

The empirical antimicrobial cycling protocol employed in this case—alternating herbal antimicrobial formulations on a weekly basis with staged reintroduction of probiotics and prebiotics—was designed to address potential overgrowth while minimizing selection pressure for resistant organisms. The complete symptomatic resolution associated with this intervention supports the hypothesis that functional bacterial overgrowth or dysbiosis was present despite negative objective testing. The patient's broader immune dysregulation (autoimmune thyroiditis, psoriasis) and significant antibiotic history provide biological plausibility for gut microbiome disruption as an underlying mechanism.

Important limitations of this case include the absence of objective biomarker confirmation of bacterial overgrowth, the uncontrolled nature of the intervention (multiple simultaneous dietary and supplement modifications), the lack of randomization or blinding, and the single-patient design precluding generalizability. Potential confounders include concurrent dietary restriction, natural symptom variability, and placebo effects. The patient's decision to extend antimicrobial therapy beyond the planned protocol and decline probiotic supplementation also limits assessment of the intended treatment algorithm. Further investigation is needed to determine whether similar clinical patterns predict response to empirical antimicrobial therapy in larger populations, whether alternative diagnostic approaches (small bowel aspirate culture, metabolomic profiling) might identify occult overgrowth, and whether treatment durability persists at longer follow-up intervals. Nonetheless, this case demonstrates that when clinical reasoning strongly suggests a functional gastrointestinal diagnosis despite negative standard testing, empirical intervention based on pattern recognition may offer therapeutic benefit.